“…The main reasons for such inconsistency are (1) the extremely reduced case/control cohort sizes analysed, which had led most likely to many type I and II errors in statistical hypothesis testing, and (2) the poor clinical characterisation of the patients included. Replicated associations of NOA-specific candidate genes include AR (see above) [143,144], PIWIL4 (PIWI-like 4, MIM*610315, encoding a key molecule for retrotransposon silencing in the germ line) [145][146][147], MTHFR (methylenetetrahydrofolate reductase, MIM*607093; an important regulatory gene involved in folate metabolism) [148][149][150], MTR (5-methyltetrahydrofolate-homocysteine S-methyltransferase, MIM*156570; responsible for the regeneration of methionine from homocysteine by transferring of a methyl group) [149,151], NOS3 (nitric oxide synthase 3, MIM*163729; involved in the release of nitric oxide for the regulation of the reproductive function) [152,153], and H2BFWT (H2B histone family, member W, testis-specific, MIM*300507, a testis-specific histone variant gene related to spermatogenesis) [154][155][156].…”